Alterity Therapeutics has shown its Multiple System Atrophy drug ATH-434 has a potential market value of US$2.4 billion if ...
The ASX closed 0.16% lower on September 30, 2025 after the RBA kept the cash rate on hold at 3.6% at its latest meeting.
Explore the Fight Retinal Blindness! Project, a global registry enhancing VEGF inhibitor treatment outcomes with ...
The human body requires protein as one of its fundamental nutritional elements, and it is known as the 'building block of the ...
D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...
Objectives Structural MRI of the brain is routinely performed on patients referred to memory clinics; however, resulting ...
The F-15C/D Eagle was the United States Air Force’s pure air-superiority champion for roughly four decades. -Conceived when ...
Dear Dr. Roach: I had a pituitary tumor that was discovered over 25 years ago. For years, I had an MRI with and without dye every six months. Then it changed to once a year. Can you get damage from ...
The largest study of its kind has found menopause is not associated with an increased risk of disability in women with ...
The largest study of its kind has found menopause is not associated with an increased risk of disability in women with ...
A growing list of contemporary phase 3 trials have shown that more drugs (quadruplet therapies) are superior to less drugs ...